Souliotis V L, Chhabra S, Anderson L M, Kyrtopoulos S A
Laboratory of Chemical Carcinogenesis, National Hellenic Research Foundation, Athens, Greece.
Carcinogenesis. 1995 Oct;16(10):2381-7. doi: 10.1093/carcin/16.10.2381.
Groups of female Wistar Furth/NCr rats, aged 6 weeks or 7 months at the start of the experiment, were administered drinking water containing N-nitrosodimethylamine (NDMA) for up to 28 days at concentrations in the range 0.2-2.64 p.p.m., resulting in daily intakes in the range 28-372 micrograms/kg/day at age 10 weeks. The levels of the premutagenic DNA adduct O6-methylguanine (O6-meG) in liver and blood leukocyte DNA were measured at different times during this exposure as well as on the days immediately following cessation of exposure. The adduct was found to accumulate rapidly in both tissues, reaching within 2-7 days steady states in the range 0.08-0.45 mumol/molG, similar in young and adult animals. Accumulation of O6-meG in blood leukocytes was approximately 30% lower than in the liver. Following cessation of NDMA treatment, adducts were lost rapidly from the DNA of both tissues, with an apparent t1/2 of approximately 19-23 h for the liver and 30-35 h for blood leukocytes. No change in liver O6-alkylguanine-DNA alkyltransferase (AGT) took place throughout this treatment. The steady-state adduct levels were approximately linearly related to NDMA dose-rate, except that a clear break (corresponding to a 2.6-fold lower slope) was observed at dose rates > 0.4 p.p.m. (approximately 56 micrograms/kg/day). This dose-response relationship is in contrast to the sharp increase in the liver tumour induction in rats chronically treated with similar concentrations of NDMA reported by Peto et al. (Cancer Res., 51, 6415-6451) and suggests that accumulation of O6-meG cannot by itself account for the hepatocarcinogenic efficacy of NDMA in the rat. Following i.g. administration of single doses of NDMA in a range approximately corresponding to the daily intake during the above mentioned chronic exposure study (25, 50 or 100 micrograms/kg), repair of O6-meG followed sharply biphasic kinetics in both liver and blood leukocytes. In the liver, an initial rapid phase (t1/2 approximately 1.5-1.7 h) was followed by much slower repair (t1/2 approximately 20.7-24.9 h) despite the absence of any change in AGT. Extrapolation of the two segments of the repair kinetics plots back to 0 time suggests that approximately 52-61% of the adducts originally formed in the liver and 33-35% of those formed in blood leukocytes belonged to the rapidly repaired category.(ABSTRACT TRUNCATED AT 400 WORDS)
在实验开始时,选用6周龄或7月龄的雌性Wistar Furth/NCr大鼠,让它们饮用含有N-亚硝基二甲胺(NDMA)的水,持续28天,浓度范围为0.2 - 2.64 ppm,在10周龄时,每日摄入量范围为28 - 372微克/千克/天。在暴露期间的不同时间以及暴露停止后的紧接着几天,测量肝脏和血液白细胞DNA中前诱变DNA加合物O6-甲基鸟嘌呤(O6-meG)的水平。发现该加合物在两种组织中迅速积累,在2 - 7天内达到稳定状态,范围为0.08 - 0.45微摩尔/摩尔G,在幼年和成年动物中相似。血液白细胞中O6-meG的积累比肝脏中低约30%。停止NDMA处理后,两种组织DNA中的加合物迅速丢失,肝脏中表观半衰期约为19 - 23小时,血液白细胞中为30 - 35小时。在整个处理过程中,肝脏O6-烷基鸟嘌呤-DNA烷基转移酶(AGT)没有变化。除了在剂量率> 0.4 ppm(约56微克/千克/天)时观察到明显的断点(对应斜率低2.6倍)外,稳态加合物水平与NDMA剂量率大致呈线性关系。这种剂量反应关系与Peto等人报道的用相似浓度的NDMA长期处理大鼠时肝脏肿瘤诱导的急剧增加形成对比(《癌症研究》,51,6415 - 6451),表明O6-meG的积累本身不能解释NDMA在大鼠中的肝癌致癌作用。经口给予单剂量的NDMA,其范围大致对应于上述慢性暴露研究期间的每日摄入量(25、50或100微克/千克),肝脏和血液白细胞中O6-meG的修复遵循明显的双相动力学。在肝脏中,最初是快速阶段(半衰期约1.5 - 1.7小时),随后是慢得多的修复阶段(半衰期约20.7 - 24.9小时),尽管AGT没有任何变化。将修复动力学曲线的两段外推到0时间表明,肝脏中最初形成的加合物约52 - 61%以及血液白细胞中形成的加合物33 - 35%属于快速修复类别。(摘要截断于400字)